Copyright
©The Author(s) 2005.
World J Gastroenterol. Sep 28, 2005; 11(36): 5696-5700
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5696
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5696
Immunoreactivity/response | P | ||||
p53 | - | - | + | + | 0.027 |
CDC25B | + | - | + | - | |
Responder | 9 | 5 | 9 | 2 | |
Non-responder | 0 | 1 | 3 | 7 | |
MT | - | - | + | + | |
0.0305 | |||||
CDC25B | + | - | + | - | |
Responder | 16 | 5 | 2 | 2 | |
Non-responder | 2 | 3 | 1 | 5 |
- Citation: Sunada F, Itabashi M, Ohkura H, Okumura T. p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy. World J Gastroenterol 2005; 11(36): 5696-5700
- URL: https://www.wjgnet.com/1007-9327/full/v11/i36/5696.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i36.5696